Synergistic Activity of the c-Met and Tubulin Inhibitor Tivantinib (ARQ197) with Pemetrexed in Mesothelioma Cells
Journal:
Current Drug Targets
Volume:
15
Page:
1331-1340
Author(s):
Leticia G. Leon, Maria Gemelli, Rocco Sciarrillo, Amir Avan, Niccola Funel and Elisa Giovannetti
Editorial: New Strategies and Applications for Drugs Targeting EGFR and c-Met
Journal:
Current Drug Targets
Volume:
15
Page:
1261-1262
Author(s):
E. Giovannetti and L.G. Leon
Cancer Stem Cells: The ‘Achilles Heel’ of Chemo-Resistant Tumors
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
10
Page:
2-22
Author(s):
In-Sun Hong, Hwa-Yong Lee and Jeong-Seok Nam
Pharmacological Therapy of Pericardial Diseases
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
525-530
Author(s):
Massimo Imazio and Yehuda Adler
Advances in Nanomedicine Towards Clinical Application in Oncology and Immunology
Journal:
Current Pharmaceutical Biotechnology
Volume:
15
Page:
864-879
Author(s):
Eduardo Herreros, Sebastian Morales, Cristian Cortes, Mauricio Cabana, Juan P. Penaloza, Lilian Jara, Daniela Geraldo, Carolina Otero and Ricardo Fernandez-Ramires
Cholinergic Receptors as Target for Cancer Therapy in a Systems Medicine Perspective
Journal:
Current Molecular Medicine
Volume:
14
Page:
1126-1138
Author(s):
P. Russo, A. Del Bufalo, M. Milic, G. Salinaro, M. Fini and A. Cesario
Combining Oncolytic Virotherapy and Cytotoxic Therapies to Fight Cancer
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
6513-6521
Author(s):
Cristina Fillat, Maria Victoria Maliandi, Ana Mato-Berciano and Ramon Alemany
Design, Synthesis and Screening Studies of Potent Thiazol-2-Amine Derivatives as Fibroblast Growth Factor Receptor 1 Inhibitors
Journal:
Current Topics in Medicinal Chemistry
Volume:
14
Page:
2031-2041
Author(s):
B.V.S. Suneel Kumar, Narasu Lakshmi, M. Ravi Kumar, Gundla Rambabu, Thimmappa H. Manjashetty, Kalle M. Arunasree, Dharmarajan Sriram, Kavya Ramkumar, Nouri Neamati, Raveendra Dayam and J.A.R.P. Sarma
MicroRNA-dependent Regulation of Telomere Maintenance Mechanisms: A Field as Much Unexplored as Potentially Promising
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
6404-6421
Author(s):
Francesca Santambrogio, Paolo Gandellini, Graziella Cimino-Reale, Nadia Zaffaroni and Marco Folini
Telomere Recombination and the ALT Pathway: A Therapeutic Perspective for Cancer
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
6466-6471
Author(s):
Irena Draskovic and Arturo Londono-Vallejo